Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Reduced price
Pharmacogenomics An Introduction and Clinical Perspective

Pharmacogenomics An Introduction and Clinical Perspective

9780071741699
436.53 zł
414.71 zł Save 21.82 zł Tax included
Lowest price within 30 days before promotion: 414.71 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description

Publishers Note:: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product.


A COMPLETE INTRODUCTORY TEXT TO THE FIELD OF PHARMACOGENOMICS

A Doodys Core Title for 2017!

The only pharmacogenomics resource to feature a global author team comprised of PharmDs, MDs, PhDs and social scientists, Pharmacogenomics offers an essential, highly accessible survey of this dynamic discipline. You will find thorough coverage of all need-to-know topics, from individual molecules to systemic diseases, plus anexamination of the latest technologies that are constantly reshaping the field. Pharmacogenomics is cohesively organized into two sections, the first of which reviewsbasic aspects of pharmacogenomics, including ethics, regulatory, science, and drug metabolism, along with a mini course in molecular genetics and testing. The second section highlights the practical application of pharmacogenomics in cardiovascular medicine, immunology, neurology, and other specialties.

FEATURES

  • Important overview of general pharmacogenomics and pharmacogenetics concepts, including geneticvariation in signal transduction and targets, plus a review of the genetic concepts of pharmacogenomics
  • Discussion of regulatory considerations in pharmacogenomics
  • Focus on the role of health care professionals along with a review of related privacy issues,as well as broader ethical, legal, and social considerations
  • In-depth chapters on drug metabolism and transporters
  • Practical, step-by-step guidance on public access to pharmacogenomic testing and patient counseling
  • Up-to-date coverage of non-genetic influences on pharmacogenomics
  • Emphasis on gene-drug interactions
  • Numerous tables and figures
  • Chapter-ending references
  • Concise learning objectives at the beginning of each chapter
  • Case studies to familiarize you with the clinical relevance of pharmacogenomics in each specialty

Product Details
McGraw Hill / Medical
52964
9780071741699
9780071741699

Data sheet

Publication date
2012
Issue number
1
Cover
paperback
Pages count
288
Dimensions (mm)
218 x 277
Weight (g)
649

  • Section I. General Concepts
    1. Developing Perspectives on Pharmacogenomics
    2. Genetic Concepts of Pharmacogenomics: Basic Review of DNA, Genes, Polymorphisms, Haplotypes and Nomenclature
    3. Analytical Methods to Identify Genetic Variations and Bioinformatics
    4. Regulatory Considerations in Pharmacogenomics at EMA and US FDA
    5. Ethical, Legal, and Social Issues Associated with Pharmacogenomics
    6A. Pharmacogenetics of Cytochrome P450
    6B. Phase II Drug-Metabolizing Enzymes
    7. Drug Transporters
    8. Nongenetic Influences on Drug Metabolism
    9. Public Access to Pharmacogenomic Testing and Patient Counseling
    10. Understanding the Use of Pharmacoeconomic Analysis to Assess the Economic Impact of Pharmacogenomic Testing

    Section II. Clinical Application of Pharmacogenomics
    11. Cardiovascular Pharmacogenomics
    12. Pharmacogenomics and Pharmacogenetics for Infectious Diseases
    13. Pharmacogenomics in Oncology
    14. Psychiatry and Addiction Medicine
    15. Immunology,Transplantation,and Vaccines
    16. Pharmacogenomics in Neurology
    17A. Pharmacogenomics of Gastrointestinal Drugs: Focus on Proton Pump Inhibitors
    17B. Genomics and the Kidney

    Index

Comments (0)
Viewed products